Treatment may not be necessary unless they cause pain. These calcifications are common, particularly in the pelvis. They are not usually a cause for concern and are rarely painful. However ...
The European Medicines Agency’s (EMA) human medicines committee has recommended Krystal Biotech’s Vyjuvek (beremagene geperpavec) to treat patients with the ultra-rare genetic blistering disease ...
for the treatment of wounds in patients with dystrophic epidermolysis bullosa (DEB) who have mutations in the collagen type VII alpha 1 chain (COL7A1) gene, starting from birth. The CHMP’s positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback